Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
INFLAMMATORY BOWEL DISEASE THERAPEUTIC AGENT OR PROPHYLACTIC AGENT
Document Type and Number:
WIPO Patent Application WO/2019/022234
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide an inflammatory bowel disease therapeutic agent or prophylactic agent that has an RORγ antagonist activity. In order to achieve this purpose, the present invention provides an inflammatory bowel disease therapeutic agent or prophylactic agent that contains, as an active ingredient, a cyclic amine derivative represented by the indicated compound or a pharmacologically acceptable salt thereof.

Inventors:
HAYASHI SHINNOSUKE (JP)
VALLET MARTIAL (JP)
YOKOSAKA SHINYA (JP)
OSUMI KAZUYA (JP)
AOKI TAKUMI (JP)
MEGURO HIROYUKI (JP)
KAINO MIE (JP)
TAKAGAKI KOZUE (JP)
TAKAHASHI TAKEHIRO (JP)
Application Number:
PCT/JP2018/028276
Publication Date:
January 31, 2019
Filing Date:
July 27, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TORAY INDUSTRIES (JP)
International Classes:
A61K31/445; A61K31/4525; A61K31/454; A61P1/04; A61P43/00
Domestic Patent References:
WO2015103507A12015-07-09
WO2015103508A12015-07-09
WO2017131156A12017-08-03
Foreign References:
JP2015514794A2015-05-21
JP2015521193A2015-07-27
Other References:
FAUBER, B. P. ET AL.: "Discovery of 1-{4-[3-Fluoro-4((3S, 6R)-3-methyl-1, 1-dioxo-6-phenyl-[1, 2]thiazinan-2- ylmethyl)-phenyl]-piperazin-1-yl}-ethanone(GNE-3500): a potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C (RORc or RORy) Inverse Agonist", JOURNAL OF MEDICINAL CHEMISTRY, vol. 58, no. 13, 23 June 2015 (2015-06-23), pages 5308 - 5322, XP055519638
Attorney, Agent or Firm:
NAGAI Hiroshi et al. (JP)
Download PDF: